Zimmer Biomet Holdings (ZBH) Assets Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.11% |
| Dec 31, 2025 | -1.11% |
| Sep 30, 2025 | -0.45% |
| Jun 30, 2025 | -0.67% |
| Mar 31, 2025 | -2.76% |
| Dec 31, 2024 | -2.81% |
| Sep 30, 2024 | -2.23% |
| Jun 30, 2024 | -2.32% |
| Mar 31, 2024 | -2.45% |
| Dec 31, 2023 | -2.28% |
| Sep 30, 2023 | -3.52% |
| Jun 30, 2023 | -3.53% |
| Mar 31, 2023 | -4.81% |
| Dec 31, 2022 | -4.13% |
| Sep 30, 2022 | -4.19% |
| Jun 30, 2022 | -4.11% |
| Mar 31, 2022 | -4.34% |
| Dec 31, 2021 | -2.55% |
| Sep 30, 2021 | -2.35% |
| Jun 30, 2021 | -1.38% |
| Mar 31, 2021 | -1.79% |
| Dec 31, 2020 | -2.11% |
| Sep 30, 2020 | -2.08% |
| Jun 30, 2020 | -2.75% |
| Mar 31, 2020 | 8.19% |
| Dec 31, 2019 | 20.60% |
| Sep 30, 2019 | 20.25% |
| Jun 30, 2019 | 20.22% |
| Mar 31, 2019 | 20.96% |
| Dec 31, 2018 | 20.25% |
| Sep 30, 2018 | 22.09% |
| Jun 30, 2018 | 22.88% |
| Mar 31, 2018 | 25.46% |
| Dec 31, 2017 | 23.62% |
| Sep 30, 2017 | 24.63% |
| Jun 30, 2017 | 25.16% |
| Mar 31, 2017 | 25.69% |
| Dec 31, 2016 | 25.66% |
| Sep 30, 2016 | 26.95% |
| Jun 30, 2016 | 25.78% |
| Mar 31, 2016 | 26.50% |
| Dec 31, 2015 | 27.69% |
| Sep 30, 2015 | 27.24% |
| Jun 30, 2015 | 28.27% |
| Mar 31, 2015 | 17.08% |
| Dec 31, 2014 | 4.40% |
| Sep 30, 2014 | 4.81% |
| Jun 30, 2014 | 5.25% |